Latest Market News

Pengana International Equities has dismissed an unauthorized announcement about management changes and outlined plans for a shareholder buy-back and potential special dividend amid its strategic review.

Manuka Resources has officially ended its Care and Maintenance phase and is gearing up to restart gold and silver production in the second quarter of 2026. The company has secured its management team and begun ore movements, signalling a significant operational shift.

Star Minerals has obtained the crucial Native Vegetation Clearing Permit, completing all regulatory approvals to commence mining at the Tumblegum South Gold Project in Western Australia.

The South Australian Court of Appeal has overturned a 2023 government proclamation, returning the Bird in Hand Gold deposit to Terramin’s exploration licence and reshaping the company’s exploration prospects.

Dexus Convenience Retail REIT has extended its on-market securities buy-back program for another year, aiming to repurchase up to 2.5% of its securities to enhance shareholder value amid current trading conditions.

QMines Limited's latest deep drilling at Mount Mackenzie reveals multiple high-grade gold, silver, and copper zones, with geological signs pointing to a potential porphyry copper-gold system at depth.

DeSoto Resources has identified a substantial 9km-long artisanal gold mining zone at its Koba Project in Guinea’s Siguiri Basin, with high-grade samples up to 15.2g/t Au and ongoing exploration activities underway.

CVC Limited has completed the settlement of its Laverton property sale, marking the conclusion of a key transaction announced last month.

Classic Minerals has teamed up with Bain Global Resources to explore expanding its Goldbridge Processing Facility into a regional hub, aiming to boost gold production across Western Australia's Forrestania district.

Audeara Limited has initiated three new white-label Auracast™ programs with Clinico Inc., alongside launching its BT-03 Audio Broadcaster in Australia, marking a significant step in scaling its audio technology globally.

Rhythm Biosciences has achieved a significant regulatory milestone with NATA accreditation for its ColoSTAT® blood-based colorectal cancer test, enabling its commercial rollout in Australia and strengthening reimbursement prospects.

Dexus Industria REIT has announced an on-market securities buy-back targeting 2.5% of its issued securities, aiming to enhance returns for investors. The buy-back is set to commence from 24 March 2026 following a mandatory waiting period.